((RAIN)) Rainmakers-Island

[Nickelback]

AMFE (.0227) TORONTO, ON / ACCESSWIRE / December 28, 2016 /Amfil Technologies Inc. (OTC-PINK:AMFE) is pleased to announce the appointment of Mr. Brian Allossery to spearhead the sales and marketing effort of the company's GROzone technology for the medical marijuana industry. Mr. Allossery has been active and successful in the marketing and development of early stage companies and products since 1996 and Amfil expects he will be an integral asset to the company as we begin the marketing of the GROzone product lines on both the commercial and retail level.

GROzone was started in 2014 by way of a Joint Venture ("JV") with Ambrose Fillis & A.C.T.S. systems, the creators of the original ozone technology with successful installations in companies such as Nestle, Pepsi, Sysco Foods, and Sun Pacific. Through the JV, the technology was modified and developed specifically for the medical marijuana industry.

Since the inception of GROzone in 2014, our technicians have had the opportunity to beta test at a licensed marijuana production facility in Colorado, allowing them to calibrate the technology to ensure the efficacy and efficiency to specifically target both large and?small scale marijuana cultivation requirements. With the testing stage completed and interest from the cultivation industry, Amfil welcomes Mr. Allossery on board to service all?inquiries and lead the full scale drive to bring the GROzone product to market in 2017.

Further to the launch of the GROzone sales initiative, Amfil Technologies is in discussions with a company that produces a revolutionary 'rotary' hydroponic growing system, which is poised to be the future of the production and manufacturing side of the industry.?The 'rotary' system requires only a third of the floor space required by traditional hydroponic systems. This system is also stackable, which makes it possible for facilities to exponentially increase the volume of their production yields.?Amfil is in discussions to create a customized GROzone system that would be sold as an add-on?to the existing systems this company creates and sells. We hope to announce the closing of this deal in January 2017.

The company will also be making an announcement shortly, potentially revising its original estimated impact on revenues, due to the most recent acquisition of Snakes & Lagers, upwards from the originally expected $2-$3M annually, as numbers have been coming in more favorably than originally anticipated.

To learn more about the GROzone technology and product line, feel free to visit this subsidiaries website at www.grozone.biz. To learn more about Amfil Technologies Inc. please visit our website at www.amfiltech.com.

http://www.nasdaq.com/press-release/amfil-technologies-inc-provides-update-on-medical-marijuana-initiative-and-grozone-product-line-20161228-00135